These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16312324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Piperacillin: comparison of antibacterial activity in vitro during the triennium 1986-88 versus the biennium 1981-82].
    Farris AG, Goffi MB.
    Minerva Med; 1992 Mar; 83(3):141-4. PubMed ID: 1553062
    [Abstract] [Full Text] [Related]

  • 4. In-vitro evaluation of "piperacillin and tazobactum" combination in a tertiary-care hospital--a preliminary study.
    Kumari N, Mohapatra TM, Rai A, Bhattacharya SK.
    Indian J Pathol Microbiol; 2006 Jan; 49(1):57-8. PubMed ID: 16625981
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of the in vitro activity of cefotetan on bacterial strains of recent hospital isolation].
    Lembo M, Nani E, Covelli I, Anzivino D, Gulletta E.
    G Batteriol Virol Immunol; 1985 Jan; 78(7-12):224-44. PubMed ID: 3870426
    [Abstract] [Full Text] [Related]

  • 7. Cefotetan: antibacterial activity against Staphylococcus aureus in the presence of human serum.
    Edwards JR.
    Chemioterapia; 1988 Aug; 7(4):271-3. PubMed ID: 3180308
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome.
    Sádaba B, Azanza JR, Campanero MA, García-Quetglas E.
    Clin Microbiol Infect; 2004 Nov; 10(11):990-8. PubMed ID: 15522002
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
    Kuck NA, Petersen PJ, Weiss WJ, Jacobus NV, Testa RT, Tally FP.
    J Chemother; 1989 Jul; 1(4 Suppl):105-6. PubMed ID: 16312325
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro study of the sensitivity of 1030 hospital-isolated bacterial strains to aztreonam.
    Grassi L.
    Chemioterapia; 1984 Aug; 3(4):262-6. PubMed ID: 6543433
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Cefotetan vs ceftriaxone: clinical and bacteriological efficacy in complicated forms of urinary tract infection].
    D'Amato C, De Carli G, Leoni GC, Bordi E, Carvelli C, Colaiacomo M, Struglia C, Visco G.
    Clin Ter; 1989 Mar 15; 128(5):347-50. PubMed ID: 2524322
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
    Cruciani M, Navarra A, Bono L, Concia E.
    J Chemother; 1989 Jul 15; 1(4 Suppl):101-2. PubMed ID: 16312323
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.